Meeting update-Society for Neuro-Oncology 2016 annual meeting

WF-1801: Single-arm pilot study of ramipril for prevention of radiation-induced cognitive decline in glioblastoma patients receiving chemoradiotherapy.

Neuro-oncology practice·2026

Clinical perspectives for the practicing neurosurgeon on integrative multiomic analyses of aggressive meningiomas.

Neurosurgical focus·2026

Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Putative glioblastoma origin-like cells in the subventricular zone: isolation and characterization.

Experimental & molecular medicine·2026

Contemporary practice patterns in IDH-mutant glioma management: a multidisciplinary multi-institutional survey.

Journal of neuro-oncology·2026

Comparison of clinical outcomes in adamantinomatous and papillary craniopharyngioma: a baseline analysis before the targeted therapy era.

Neurosurgical focus·2026

Cancer Neuroscience: Establishing a home in Neuro-Oncology.

Neuro-oncology·2026

Glioma and ependymoma through the lens of brain development, stem cells, and plasticity.

Neuro-oncology·2026

Impact of [18F]FET-PET on MRI-Based Radiotherapy Target Volumes in Newly Diagnosed Glioblastoma:Results from the FET-PET in Glioblastoma (FIG) Study TROG 18.06.

Neuro-oncology·2026

Potentially inappropriate care at the end of life in patients with glioblastoma: A single-center observational cohort study.

Neuro-oncology·2026

Plasma proteomics for prognostic stratification in newly diagnosed primary central nervous system lymphoma.

Neuro-oncology·2026

Immune Cell Engager Therapy for Brain Cancer.

Neuro-oncology·2026

Diagnosis of Rare Cervical Tumors: IECC Classification, HPV Status, and Subtype-Directed Immunohistochemistry, with Treatment Outcomes from a Tertiary Center.

Pathogens (Basel, Switzerland)·2026

Neuroendocrine Tumors Have Outgrown the Orphan-Disease Framework: Building an Evidence Base for a Changing Field.

Cancers·2026

Correction: Feroz et al. Non-Muscle Myosin II A: Friend or Foe in Cancer? Int. J. Mol. Sci. 2024, 25, 9435.

International journal of molecular sciences·2026

Clinical characteristics and prognostic outcomes of silent corticotroph versus gonadotroph adenomas: A 603-case single-center cohort study.

Neurosurgical review·2026

Safety of laparoscopic surgery without No.253 lymph node dissection for mid and low rectal cancer (SMOOTH): study protocol for a phase III, multicentre randomised controlled trial in China.

BMJ open·2026

Emergency medical services agency-level variation in non-initiation of resuscitation and termination of resuscitation in out-of-hospital cardiac arrest.

Resuscitation·2026

Related Experiment Videos

Meeting update-Society for Neuro-Oncology 2016 annual meeting

Related Concept Videos

WF-1801: Single-arm pilot study of ramipril for prevention of radiation-induced cognitive decline in glioblastoma patients receiving chemoradiotherapy.

Clinical perspectives for the practicing neurosurgeon on integrative multiomic analyses of aggressive meningiomas.

Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.

Putative glioblastoma origin-like cells in the subventricular zone: isolation and characterization.

Contemporary practice patterns in IDH-mutant glioma management: a multidisciplinary multi-institutional survey.

Comparison of clinical outcomes in adamantinomatous and papillary craniopharyngioma: a baseline analysis before the targeted therapy era.

Cancer Neuroscience: Establishing a home in Neuro-Oncology.

Glioma and ependymoma through the lens of brain development, stem cells, and plasticity.

Impact of [18F]FET-PET on MRI-Based Radiotherapy Target Volumes in Newly Diagnosed Glioblastoma:Results from the FET-PET in Glioblastoma (FIG) Study TROG 18.06.

Potentially inappropriate care at the end of life in patients with glioblastoma: A single-center observational cohort study.

Plasma proteomics for prognostic stratification in newly diagnosed primary central nervous system lymphoma.

Immune Cell Engager Therapy for Brain Cancer.

Diagnosis of Rare Cervical Tumors: IECC Classification, HPV Status, and Subtype-Directed Immunohistochemistry, with Treatment Outcomes from a Tertiary Center.

Neuroendocrine Tumors Have Outgrown the Orphan-Disease Framework: Building an Evidence Base for a Changing Field.

Correction: Feroz et al. Non-Muscle Myosin II A: Friend or Foe in Cancer? Int. J. Mol. Sci. 2024, 25, 9435.

Clinical characteristics and prognostic outcomes of silent corticotroph versus gonadotroph adenomas: A 603-case single-center cohort study.

Safety of laparoscopic surgery without No.253 lymph node dissection for mid and low rectal cancer (SMOOTH): study protocol for a phase III, multicentre randomised controlled trial in China.

Emergency medical services agency-level variation in non-initiation of resuscitation and termination of resuscitation in out-of-hospital cardiac arrest.

Related Experiment Videos

Meeting update-Society for Neuro-Oncology 2016 annual meeting

Related Concept Videos

Related Articles